ZA896246B - Defective hepadnaviruses for vaccines and treatment of liver diseases and disorders - Google Patents

Defective hepadnaviruses for vaccines and treatment of liver diseases and disorders

Info

Publication number
ZA896246B
ZA896246B ZA896246A ZA896246A ZA896246B ZA 896246 B ZA896246 B ZA 896246B ZA 896246 A ZA896246 A ZA 896246A ZA 896246 A ZA896246 A ZA 896246A ZA 896246 B ZA896246 B ZA 896246B
Authority
ZA
South Africa
Prior art keywords
hepadnaviruses
vaccines
disorders
defective
treatment
Prior art date
Application number
ZA896246A
Other languages
English (en)
Inventor
Arthur Louis Horwich
Louis Horwich Arthur
Jesse William Summers
William Summers Jesse
Original Assignee
Univ Yale
Fox Chase Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale, Fox Chase Cancer Center filed Critical Univ Yale
Publication of ZA896246B publication Critical patent/ZA896246B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/29Hepatitis virus
    • A61K39/292Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA896246A 1988-08-16 1989-08-16 Defective hepadnaviruses for vaccines and treatment of liver diseases and disorders ZA896246B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23281188A 1988-08-16 1988-08-16

Publications (1)

Publication Number Publication Date
ZA896246B true ZA896246B (en) 1990-06-27

Family

ID=22874695

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA896246A ZA896246B (en) 1988-08-16 1989-08-16 Defective hepadnaviruses for vaccines and treatment of liver diseases and disorders

Country Status (8)

Country Link
EP (1) EP0380656A1 (da)
AU (1) AU4315689A (da)
DK (1) DK93390A (da)
FI (1) FI901876A7 (da)
IE (1) IE892640L (da)
IL (1) IL91335A0 (da)
WO (1) WO1990002176A1 (da)
ZA (1) ZA896246B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2081022A1 (en) * 1990-04-20 1991-10-21 Hubert E. Blum Methods of preventing viral replication
US5610050A (en) * 1990-04-20 1997-03-11 The General Hospital Corporation Methods of preventing viral replication
FR2716459B1 (fr) * 1994-02-22 1996-05-10 Univ Paris Curie Système hôte-vecteur utilisable en thérapie génique.
US5869248A (en) * 1994-03-07 1999-02-09 Yale University Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences
US5683873A (en) * 1995-01-13 1997-11-04 Innovir Laboratories, Inc. EGS-mediated inactivation of target RNA
US6057153A (en) * 1995-01-13 2000-05-02 Yale University Stabilized external guide sequences
DE19517532C2 (de) * 1995-05-12 1999-10-28 Max Planck Gesellschaft HBV-Vektoren und Zellen zu ihrer Bereitstellung
US5980901A (en) * 1996-09-18 1999-11-09 The Board Of Regents Of The University Of Texas System Viral defective interfering particles and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861588A (en) * 1985-02-05 1989-08-29 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers

Also Published As

Publication number Publication date
IE892640L (en) 1990-02-16
FI901876A0 (fi) 1990-04-12
WO1990002176A1 (en) 1990-03-08
DK93390A (da) 1990-06-15
DK93390D0 (da) 1990-04-11
FI901876A7 (fi) 1990-04-12
EP0380656A1 (en) 1990-08-08
IL91335A0 (en) 1990-03-19
AU4315689A (en) 1990-03-23

Similar Documents

Publication Publication Date Title
US5037384B2 (en) Method and apparatus for the treatment of complicated retinal detachments
KR0125921B1 (en) Method and device for the diagnosis and treatment of nasal diseases
HUT64699A (en) Process for production of preparations for the treatment of disorders and disearses
ZA881488B (en) New pharmaceutical compositions in the form of beadlets and method
OA09658A (en) Materials and methods for the treatment of foreign tissue
AU2690684A (en) Methods and pharmaceutical compositions for the treatment of hyperplastic diseases of the skin
GB9013408D0 (en) Process for improving the therapeutic efficacy of fat-soluble corticosteriods and composition for carrying out this process
EP0324802A4 (en) Method for the treatment of body tissues and the administration of drugs thereto
ZA896246B (en) Defective hepadnaviruses for vaccines and treatment of liver diseases and disorders
PT80658A (en) Process for the preparation of amino-acids and therapeutic method thereof
IL87524A0 (en) Pharmaceutical preparation for the treatment of sleep disorders and depression comprising a benzothiazole derivative
DK134990D0 (da) Praeparat til tandbehandling samt fremgangsmaade til fremstilling deraf
HUT49980A (en) Process for delivering and producing compositions comprising toxicants
PH24723A (en) Device and composition for treatment of the gums
HUP9800829A3 (en) Collagen-based methods and formulations for the treatment of immune system-mediated diseases
DE3570363D1 (en) Amino acid solution-containing drug for the treatment of cancerous diseases and preparation process thereof
AU3790489A (en) Composition and method for treatment of gastrointestinal disorders
HU900666D0 (en) Process for preparing the way for elimination of articulational mistake on human jaw-bone and palate
GB2170403B (en) Medicament for treatment of asthma and preparation thereof
ZM10686A1 (en) New orth-anisamides process for their preparation and their therapeutic application
GB8715914D0 (en) Treatment of cerabral disorders
GB2220652B (en) Treatment of pastures
ITMI941939A0 (it) Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids
GB2173401B (en) Pharmaceutical compositions for the treatment of cerebrovascular and aging brain disorders
IT8848116A0 (it) Composizione farmaceutica in particolare per il trattamento di alopecia e acne vulgaris e procedimento per prepararla